# MedMethod Direct Website Compliance Implementation Report

**Prepared by:** Manus AI  
**Implementation date:** August 26, 2026  
**Source instructions:** `MMD_Website_Update_Instructions_2026-08-25.docx`

This report documents the website changes completed after owner approval. It is organized using the five reporting sections requested in the instructions. The implementation aligns the site with the supplied requirements but does not guarantee certification or replace review by LegitScript or qualified regulatory counsel.

## 1. Deleted Pages and Content

The following public pages were removed from the React router or left unpublished because their primary purpose depended on prohibited brands, comparisons, programs, services, or claims.

| Removed or Unpublished URL | Action |
|---|---|
| `/male` | Male-treatment page remains deleted; a permanent redirect now sends visitors to `/`. |
| `/pricing-guide` | Comparison-based medication pricing page deleted and permanently redirected to `/`. |
| `/blog/semaglutide-vs-tirzepatide-women-midlife` | Article source, registry entry, sitemap entry, public AI-index entry, and location-page references deleted; URL permanently redirects to `/blog`. |
| `/the-menopause-weight-loss-trap` | Book marketing page deleted and permanently redirected to `/`. |
| `/guide/how-it-works` | Legacy guide deleted and permanently redirected to `/`. |
| `/before-you-start-treatment` | Legacy guide deleted and permanently redirected to `/`. |
| `/start/women` | Legacy treatment page deleted and permanently redirected to `/`. |
| `/home-1`, `/home-v1`, `/home-2`, `/home-3` | Duplicate legacy homepage routes removed and permanently redirected to `/`. |
| `/lp/hrt` | Legacy landing page removed and permanently redirected to `/lp/hrt3`. |
| `/lp/glp1` | Legacy GLP-1 alias permanently redirects to `/lp/WL`. |

Nineteen obsolete page and shared-component source files were deleted. These included hardcoded testimonial components, comparison-heavy pricing sections, transformation and longevity program cards, fitness/coaching modules, disallowed treatment sections, and the legacy pages listed above. The final project diff contains **162 changed files, 461 insertions, and 13,291 deletions**, reflecting a deletion-first remediation strategy rather than replacement medical claims.

Across active pages, complete sentences, FAQ objects, cards, metadata fields, structured-data entries, testimonial sections, quiz answers, and notification entries were deleted wherever they contained prohibited drug brands, quantified outcomes, body-composition or muscle claims, men’s treatment language, thyroid/peptide/longevity services, fitness coaching, pharmacy comparisons, or result-oriented claims.

## 2. Remaining Pages and Content

The following core public experiences remain available and were preserved during the cleanup.

| Content Area | Current Status |
|---|---|
| Main homepage `/` | Retained with approved service categories, corrected licensing copy, neutral medication guidance, and required disclosures. |
| Hormone landing page `/lp/hrt3` | Retained with prohibited claims removed and the exact Florida-only women’s-testosterone disclosure. |
| Weight-loss landing pages `/lp/WL` and `/lp/WL2` | Retained with prohibited brands, comparisons, quantified outcomes, and testimonial claims removed. |
| Locations directory `/locations` | Retained and redesigned to display the exact 12 approved jurisdictions; detailed city guides remain for the existing state pages. |
| Existing location pages | **104** location-page source files remain. Noncompliant program sections and testimonials were removed, services were restricted, and disclosures were added where required. |
| Blog index and compliant articles | Retained after removing prohibited labels, claims, and the specifically unpublished article. |
| Care-team and physician booking pages | Retained. |
| Payment and intake flows | Retained. Stripe, PayPal, GHL intake/webhook logic, $50 deposit behavior, WL2 $15 payment behavior, scheduled sweep logic, and admin payment settings were not removed. |
| Legal pages | Terms, privacy, HIPAA, consent, accessibility, subscription policy, and related legal routes remain available. |

The five approved service categories used in public service menus and intake choices are:

| Approved Service Category |
|---|
| Medical weight management, including GLP-1 treatment |
| Hormone therapy for women |
| Nutrition and vitamin optimization |
| Dermatology and skin |
| Hair restoration |

Fitness-app and Everfit language was removed rather than retained. No separate exercise coaching, personal training, workout plan, meal plan, or performance-coaching program is presented.

## 3. URLs and Redirects

All discontinued public routes listed below are handled by server-side **HTTP 301** redirects before the SPA, crawler metadata, or static fallback. This prevents a removed page from returning a misleading HTTP 200 response.[1]

| Old URL | Permanent Destination |
|---|---|
| `/male` | `/` |
| `/before-you-start-treatment` | `/` |
| `/the-menopause-weight-loss-trap` | `/` |
| `/guide/how-it-works` | `/` |
| `/start/women` | `/` |
| `/pricing-guide` | `/` |
| `/blog/semaglutide-vs-tirzepatide-women-midlife` | `/blog` |
| `/home-1`, `/home-v1`, `/home-2`, `/home-3` | `/` |
| `/lp/hrt` | `/lp/hrt3` |
| `/lp/glp1` | `/lp/WL` |

Both footer variants were audited. Placeholder social links, disallowed service labels, obsolete company links, the longevity tagline, and misleading “discovery call” language were removed. Every remaining internal footer destination returned HTTP 200 during local verification.

## 4. Licensing Statements

The approved licensing scope is now stated as **12 jurisdictions**:

| Approved Jurisdictions |
|---|
| Arizona |
| Colorado |
| District of Columbia |
| Florida |
| Maryland |
| Nevada |
| North Carolina |
| Oregon |
| Pennsylvania |
| Texas |
| Virginia |
| West Virginia |

All outdated 9-state, 17-state, and five-state counts were removed. Tennessee, New Jersey, Alabama, Washington State, and Ohio were removed from licensing statements and social-proof location arrays. “Washington DC” references were retained only where they refer to the approved District of Columbia.

The locations page no longer uses the stale nine-state map or “expanding nationwide/all 50 states” messaging. It now displays the exact 12-jurisdiction list in visible page content, metadata, and structured data. Existing detailed location guides are labeled separately so they are not presented as the full licensing list.

The Terms of Service eligibility section and public AI/indexing reference file were also corrected to the same jurisdiction set.

## 5. Required Disclaimers

The project now uses a shared readable disclosure component to keep the mandated wording consistent.[2]

### Compounded Medication Disclosure

> Compounded medications are not FDA-approved. They are prepared by licensed compounding pharmacies for an individual patient based on a prescription. FDA-approved alternatives are available and will be discussed with you by your physician. Results vary. Treatment requires ongoing medical monitoring.

This exact wording is placed on every remaining page that mentions compounded semaglutide or compounded tirzepatide. The final source audit identified **92** page/article placements with compounded-treatment content and required disclosure coverage.

### Florida Women’s Testosterone Disclosure

> Testosterone is prescribed off-label for hypoactive sexual desire disorder in women. There is no FDA-approved testosterone product for women in the United States. This treatment is available only to patients in Florida.

All non-Florida location references to testosterone treatment for women were removed. The final source audit identified **14** Florida/HRT page placements using the exact required disclosure.

### Validation Evidence

| Validation | Result |
|---|---|
| TypeScript | Passed with no errors |
| Automated tests | **114 passed across 22 test files** |
| Production build | Passed |
| Compliance regression suite | Passed all state, brand, claim, service, disclosure, route, and footer checks[3] |
| Final prohibited-content scans | Zero matches for removed states, banned brands, body claims, outcome claims, drug comparisons, disallowed services, prohibited fitness language, and outdated state counts |
| Redirect checks | All listed discontinued URLs returned HTTP 301 |
| Footer-link checks | All remaining local footer destinations returned HTTP 200 |
| Representative visual checks | Homepage, HRT landing page, WL2 landing page, locations page, and Terms page rendered after the cleanup |
| PayPal public configuration endpoint | Returned HTTP 200 after the implementation |

## References

[1]: ../server/_core/index.ts "Permanent compliance and legacy-route redirects"
[2]: ../client/src/components/ComplianceDisclosures.tsx "Shared exact compliance disclosures"
[3]: ../server/legitScriptCompliance.test.ts "Automated LegitScript compliance regression suite"
